Search Results | Diabetes Care | American Diabetes Association

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Clinical and Economic Benefits Associated With the Achievement of Both HbA_1c and LDL Cholesterol Goals in Veterans With Type 2 Diabetes

Lizheng Shi, PHD, Xin Ye, PHD, Mei Lu, MS, Eric Q. Wu, PHD, Hari Sharma, BS, Darren Thomason, BA, Vivian A. Fonseca, MD

Diabetes Care 2013;36(10):3297–3304

DOI: https://doi.org/10.2337/dc13-0149

Published: 14 September 2013

View article

Includes: Supplementary data

Journal Articles

Screening Patients With Type 2 Diabetes for Active Tuberculosis in Communities of China

Wenjing Zhao, MHA, Lizheng Shi, PHD, Vivian A. Fonseca, MD, Jiang He, PHD, Decheng Shao, MBBS, Jie Zhao, MBBS, Qingmei Chen, MHA, Aitian Yin, MBBS

Diabetes Care 2013;36(9):e159–e160

DOI: https://doi.org/10.2337/dc13-1007

Published: 13 August 2013

View article

Journal Articles

Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes: Basal Plus Trial

Guillermo E. Umpierrez, MD, Dawn Smiley, MD, Kathie Hermayer, MD, Amna Khan, MD, Darin E. Olson, MD, Christopher Newton, MD, Sol Jacobs, MD, Monica Rizzo, MD, Limin Peng, PHD, David Reyes, MD, Ingrid Pinzon, MD, Maria Eugenia Fereira, MD, Vicky Hunt, BA, Ashwini Gore, MD, Marcos T. Toyoshima, MD, Vivian A. Fonseca, MD

Diabetes Care 2013;36(8):2169–2174

DOI: https://doi.org/10.2337/dc12-1988

Published: 11 July 2013

View article

Includes: Supplementary data

Journal Articles

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy: A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)

Vivian A. Fonseca, MD, Ricardo Alvarado-Ruiz, MD, Denis Raccah, MD, Gabor Boka, MD, Patrick Miossec, MD, John E. Gerich, MD, on behalf of the EFC6018 GetGoal-Mono Study Investigators

Diabetes Care 2012;35(6):1225–1231

DOI: https://doi.org/10.2337/dc11-1935

Published: 11 May 2012

View article

Includes: Supplementary data

Journal Articles

The American Diabetes Association Diabetes Research Perspective

Vivian A. Fonseca, MD, M. Sue Kirkman, MD, Tamara Darsow, PHD, Robert E. Ratner, MD

Diabetes Care 2012;35(6):1380–1387

DOI: https://doi.org/10.2337/dc12-9001

Published: 11 May 2012

View article

Journal Articles

Iron and Diabetes Revisited

Sudhir V. Shah, MD, Vivian A. Fonseca, MD

Diabetes Care 2011;34(7):1676–1677

DOI: https://doi.org/10.2337/dc11-0700

Published: 17 June 2011

View article

Journal Articles

Finishing Strong

Vivian A. Fonseca, MD

Diabetes Care 2011;34(1):1

DOI: https://doi.org/10.2337/dc10-1990

Published: 01 January 2011

View article

Journal Articles

The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

Julio Rosenstock, MD, Salomon Banarer, MD, Vivian A. Fonseca, MD, Silvio E. Inzucchi, MD, William Sun, PHD, Wenqing Yao, PHD, Gregory Hollis, PHD, Robert Flores, BSN, Richard Levy, MD, William V. Williams, MD, Jonathan R. Seckl, MD, Reid Huber, PHD, for the INCB13739-202 Principal Investigators

Diabetes Care 2010;33(7):1516–1522

DOI: https://doi.org/10.2337/dc09-2315

Published: 22 April 2010

View article

Includes: Supplementary data

Journal Articles

Effect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup Characteristics: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

Jorge Calles-Escandón, MD, Laura C. Lovato, MS, Denise G. Simons-Morton, MD, PHD, David M. Kendall, MD, Rodica Pop-Busui, MD, Robert M. Cohen, MD, Denise E. Bonds, MD, Vivian A. Fonseca, MD, Faramarz Ismail-Beigi, MD, PHD, Mary Ann Banerji, MD, Alan Failor, MD, Bruce Hamilton, MD

Diabetes Care 2010;33(4):721–727

DOI: https://doi.org/10.2337/dc09-1471

Published: 26 January 2010

View article

Includes: Supplementary data

Journal Articles

Changes in Prandial Glucagon Levels After a 2-Year Treatment With Vildagliptin or Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

Bo Ahrén, MD, PHD, James E. Foley, PHD, Ele Ferrannini, MD, David R. Matthews, MD, Bernard Zinman, MD, Sylvie Dejager, MD, PHD, Vivian A. Fonseca, MD, FRCP

Diabetes Care 2010;33(4):730–732

DOI: https://doi.org/10.2337/dc09-1867

Published: 12 January 2010

View article

Journal Articles

Diabetes Care: Making a Good Journal Better

Vivian A. Fonseca, MD

Diabetes Care 2010;33(1):1–2

DOI: https://doi.org/10.2337/dc09-1864

Published: 01 January 2010

View article

Journal Articles

Defining and Characterizing the Progression of Type 2 Diabetes

Vivian A. Fonseca, MD

Diabetes Care 2009;32(suppl_2):S151–S156

DOI: https://doi.org/10.2337/dc09-S301

Published: 01 November 2009

View article

Journal Articles

Bile Acids and Metabolic Regulation: Mechanisms and clinical responses to bile acid sequestration

Bart Staels, PHD, Vivian A. Fonseca, MD

Diabetes Care 2009;32(suppl_2):S237–S245

DOI: https://doi.org/10.2337/dc09-S355

Published: 01 November 2009

View article

Journal Articles

Comparison of A1C and Fasting Glucose Criteria to Diagnose Diabetes Among U.S. Adults

April P. Carson, PHD, Kristi Reynolds, PHD, Vivian A. Fonseca, MD, Paul Muntner, PHD

Diabetes Care 2010;33(1):95–97

DOI: https://doi.org/10.2337/dc09-1227

Published: 06 October 2009

View article

Includes: Supplementary data

Journal Articles

Impact of a Natural Disaster on Diabetes: Exacerbation of disparities and long-term consequences

Vivian A. Fonseca, MD, MRCP, FACE, Hayden Smith, MPH, Nitesh Kuhadiya, MD, MPH, Sharice M. Leger, BS, C. Lillian Yau, PHD, Kristi Reynolds, PHD, MPH, Lizheng Shi, PHD, MAMS, Roberta H. McDuffie, MSN, BSBA, APRN, BC, CNS, Tina Thethi, MD, MPH, Jennifer John-Kalarickal, MD

Diabetes Care 2009;32(9):1632–1638

DOI: https://doi.org/10.2337/dc09-0670

Published: 19 June 2009

View article

Journal Articles

The Human Side of Diabetes Care

Vivian A. Fonseca, MD

Diabetes Care 2009;32(1):1–2

DOI: https://doi.org/10.2337/dc08-1873

Published: 01 January 2009

View article

Journal Articles

Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy

Vivian A. Fonseca, MD, Julio Rosenstock, MD, Antonia C. Wang, PHD, Kenneth E. Truitt, MD, Michael R. Jones, PHD

Diabetes Care 2008;31(8):1479–1484

DOI: https://doi.org/10.2337/dc08-0283

Published: 01 August 2008

View article

Includes: Supplementary data

Journal Articles

Is the Combination of Sulfonylureas and Metformin Associated With an Increased Risk of Cardiovascular Disease or All-Cause Mortality?: A meta-analysis of observational studies

Ajay D. Rao, MD, Nitesh Kuhadiya, MBBS, Kristi Reynolds, PHD, MPH, Vivian A. Fonseca, MD

Diabetes Care 2008;31(8):1672–1678

DOI: https://doi.org/10.2337/dc08-0167

Published: 01 August 2008

View article

Journal Articles

Diabetes Care: Moving (a Little) in the Winds of Change

Vivian A. Fonseca, MD, FRCP

Diabetes Care 2008;31(1):1–2

DOI: https://doi.org/10.2337/dc07-2052

Published: 01 January 2008

View article

Journal Articles

The Role of Iron in Diabetes and Its Complications

Sundararaman Swaminathan, MD, Vivian A. Fonseca, MD, Muhammad G. Alam, MD, MPH, Sudhir V. Shah, MD

Diabetes Care 2007;30(7):1926–1933

DOI: https://doi.org/10.2337/dc06-2625

Published: 01 July 2007

View article

NARROW

Clinical and Economic Benefits Associated With the Achievement of Both HbA_1c and LDL Cholesterol Goals in Veterans With Type 2 Diabetes

Screening Patients With Type 2 Diabetes for Active Tuberculosis in Communities of China

Randomized Study Comparing a Basal-Bolus With a Basal Plus Correction Insulin Regimen for the Hospital Management of Medical and Surgical Patients With Type 2 Diabetes: Basal Plus Trial

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy: A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)

The American Diabetes Association Diabetes Research Perspective

Iron and Diabetes Revisited

Finishing Strong

The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

Effect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup Characteristics: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

Changes in Prandial Glucagon Levels After a 2-Year Treatment With Vildagliptin or Glimepiride in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

Diabetes Care: Making a Good Journal Better

Defining and Characterizing the Progression of Type 2 Diabetes

Bile Acids and Metabolic Regulation: Mechanisms and clinical responses to bile acid sequestration

Comparison of A1C and Fasting Glucose Criteria to Diagnose Diabetes Among U.S. Adults

Impact of a Natural Disaster on Diabetes: Exacerbation of disparities and long-term consequences

The Human Side of Diabetes Care

Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy

Is the Combination of Sulfonylureas and Metformin Associated With an Increased Risk of Cardiovascular Disease or All-Cause Mortality?: A meta-analysis of observational studies

Diabetes Care: Moving (a Little) in the Winds of Change

The Role of Iron in Diabetes and Its Complications

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only